Fintel reports that on January 16, 2025, Cantor Fitzgerald initiated coverage of Palantir Technologies (NasdaqGS:PLTR) with a ...

Analysts at Cantor Fitzgerald upped their FY2024 earnings per share (EPS) estimates for shares of Rigel Pharmaceuticals in a ...

Cantor Fitzgerald analyst Sarah James initiated coverage with a Buy rating on UnitedHealth (UNH – Research Report) yesterday and set a price ...

Analysts at Cantor Fitzgerald issued their FY2024 earnings per share estimates for Nova in a report issued on Monday, January 13th. Cantor Fitzgerald analyst M. Prisco forecasts that the semiconductor ...

Cantor Fitzgerald initiated coverage of Datadog (DDOG) with an Overweight rating and $180 price target Stay Ahead of the Market:Discover ...

Cantor Fitzgerald Equity Opportunity Fd earns a Low Process Pillar rating. The primary detractor from the rating is the fund's unimpressive long-term risk-adjusted performance. This can be seen in ...

Tripadvisor Inc Common Stock (TRIP) stock saw a modest uptick, ending the day at $15.26 which represents a slight increase of $0.44 or 2.97% from the prior close of $14.82. The stock opened at $15.21 ...

Cantor Fitzgerald reiterates an Overweight rating on Avita Medical (RCEL) following the company receiving FDA premarket approval for RECELL GO Mini, its miniaturized device designed to treat ...

Cantor Fitzgerald analyst Deepak Mathivanan downgraded Sabre (SABR) to Neutral from Overweight with a price target of $4, down from $5, after assuming coverage of the name. Cantor expects fiscal ...

Cantor Equity Partners I, Inc. (Nasdaq: CEPO) (the "Company") announced today that it closed its initial public offering ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...